“Dr Reddy’s Shares Seek Therapy Post Target Cut: Are Pharma Stocks Developing Anxiety Disorders?”
Mumbai — The bustling heart of Indian commerce was abuzz on Wednesday as Dr Reddy’s Laboratories’ shares showed symptoms of what experts are now diagnosing as Acute Value Anxiety Disorder (AVAD). This comes after Citi lobbed a metaphorical gurney at the company’s share price target, performing a stunning slashing ritual of 28% due to Semaglutide … Read more